Europe — EMA

Paclitaxel Accord

Paclitaxel, the active ingredient in Paclitaxel Accord, is a taxane presented as a strength/form for intravenous use. It treats various solid tumours and is administered in oncology patients.

Paclitaxel

Request sourcing

Pack/s

What is Paclitaxel?

Paclitaxel, the active ingredient in Paclitaxel Accord, is a taxane presented as a strength/form for intravenous use. It treats various solid tumours and is administered in oncology patients. GNH USA supplies Paclitaxel Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Paclitaxel Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Paclitaxel used for?

Paclitaxel is a chemotherapy agent that interferes with cell division in several cancer pathways.

- Breast cancer: improves the overall response rate and survival in adjuvant and metastatic settings. - Ovarian cancer: used as first‑line therapy in combination with carb‑ carb cis‑c c c c. - Non‑small cell lung c - . - .

What are the side effects of Paclitaxel?

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →